CECOCECO to Showcase ArtMorph Innovation at AIA Conference on Architecture & Design 2025
BOSTON, May 22, 2025 — Lighting and display innovator CECOCECO will attend the AIA Conference on Architecture & Design 2025 […]
Adagene Presents Updated Phase 1b/2 Data on Muzastotug (ADG126) Plus KEYTRUDA® (pembrolizumab) in Colorectal Cancer at ASCO
The CTLA-4 inhibitor ADG126, when combined with pembrolizumab, can be administered at a dose of 20 mg/kg every six weeks […]